Gene · 9444
Papers1,732
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,732
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CircFLNB upregulated by chemotherapy via alternative splicing suppresses the progression of colorectal cancer. | Cancer Lett | 2025 | 40684838 | PubTator, text mining | PubMed |
| Fork Stalling and Template Switching in a Complex der(6)dn with Duplication of 6q24.3qter and 6p25.3: A Case Report. | Cytogenet Genome Res | 2025 | 40675132 | PubTator, text mining | PubMed |
| HIV-1 Vpr orchestrates ciTRAN upregulation through TGF-β induction. | PLoS Pathog | 2025 | 40632811 | PubTator, text mining | PubMed |
| CircERC1 facilitates chemoresistance through inhibiting pyroptosis and remodeling extracellular matrix in pancreatic cancer. | Mol Cancer | 2025 | 40605033 | PubTator, text mining | PubMed |
| Quaking Protein in Myelin Maintenance and Regeneration in the Central Nervous System. | Mol Neurobiol | 2025 | 40555892 | PubTator, text mining | PubMed |
| Biological function of RNA-binding proteins in myocardial infarction: a potential emerging therapeutic limelight. | Cell Biosci | 2025 | 40413549 | PubTator, text mining | PubMed |
| KHSRP promotes the malignant behavior and cisplatin resistance of bladder cancer cells through the CLASP2/MAPRE1 axis. | Pharmacogenomics J | 2025 | 40382315 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of MEX3 family genes in hepatocellular carcinoma. | Sci Rep | 2025 | 40374855 | PubTator, text mining | PubMed |
| Failure mechanisms and reinforcement of pipe-framed solar greenhouses under snow loads. | Sci Rep | 2025 | 40355581 | PubTator, text mining | PubMed |
| QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203/PPP1R3C/mTOR/Myc axis. | Cell Death Discov | 2025 | 40263288 | PubTator, text mining | PubMed |
| Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2025 | 40227722 | PubTator, text mining | PubMed |
| Alternative splicing of the Snap23 microexon is regulated by MBNL, QKI, and RBFOX2 in a tissue-specific manner and is altered in striated muscle diseases. | RNA Biol | 2025 | 40207498 | PubTator, text mining | PubMed |
| Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma. | Cancer Biomark | 2025 | 40171812 | PubTator, text mining | PubMed |
| RBPsuite 2.0: an updated RNA-protein binding site prediction suite with high coverage on species and proteins based on deep learning. | BMC Biol | 2025 | 40069726 | PubTator, text mining | PubMed |
| BiFC and FACS-based CRISPR screening revealed that QKI promotes PABPN1 LLPS in colorectal cancer cells. | Protein Cell | 2025 | 40052530 | PubTator, text mining | PubMed |
| CircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11. | Mol Cancer | 2025 | 39994725 | PubTator, text mining | PubMed |
| Investigating Gene Expression Noise Reduction by MicroRNAs and MiRISC Reinforcement by Self-Feedback Regulation of mRNA Degradation. | bioRxiv | 2025 | 39990448 | PubTator, text mining | PubMed |
| Upregulation of YY1 in M2 macrophages promotes secretion of exosomes containing hsa-circ-0000326 via super-enhancers to facilitate prostate cancer progression. | Mol Cell Biochem | 2025 | 39960585 | PubTator, text mining | PubMed |
| Generative modeling for RNA splicing predictions and design. | bioRxiv | 2025 | 39896553 | PubTator, text mining | PubMed |
| RNA-binding protein quaking: a multifunctional regulator in tumour progression. | Ann Med | 2025 | 39711373 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9444/papers?page=4